Compare EVO & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | CMP |
|---|---|---|
| Founded | 1993 | 1993 |
| Country | Germany | United States |
| Employees | 4766 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 895.8M | 1.0B |
| IPO Year | N/A | 2003 |
| Metric | EVO | CMP |
|---|---|---|
| Price | $2.58 | $22.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $7.00 | ★ $21.50 |
| AVG Volume (30 Days) | 107.5K | ★ 530.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.13 | $2.25 |
| P/E Ratio | ★ N/A | $54.40 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $8.60 |
| 52 Week High | $4.80 | $27.00 |
| Indicator | EVO | CMP |
|---|---|---|
| Relative Strength Index (RSI) | 45.13 | 46.16 |
| Support Level | $2.32 | $22.23 |
| Resistance Level | $3.82 | $25.80 |
| Average True Range (ATR) | 0.07 | 1.03 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 98.11 | 42.11 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.